Omega Protein Acquires Specialist in Omega-3 Purification
The company has acquired InCon Processing, a company with expertise in molecular distillation.
Omega-3 ingredient supplier Omega Protein Corp. (Houston) has acquired InCon Processing LLC (Batavia, IL), a company focused on purifying specialty nutritional and synthetic compounds, with expertise in molecular distillation.
“InCon enables us to provide our customers with an enhanced range of omega-3 fish oils in concentrated forms such as ethyl esters and triglycerides that we have not been able to offer before,” stated Joe von Rosenberg, Omega Protein’s chairman of the board, president, and CEO, to the press.
Omega Protein will market the concentrated fish oils produced by InCon as part of its OmegaActiv omega-3 portfolio, which is overseen by Omega Protein subsidiary Cyvex Nutrition.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
